Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Phoenix Children's Hospital, Phoenix, Arizona USC /Norris Comprehensive Cancer Center University of Southern California, Los Angeles, California Children's Hospital of Philadelphia, Philadelphia, Pennsylvania